You are here

Article Text

Article menu
Download PDFPDF
CASE REPORT
Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis
  1. Yavuz Pehlivan1,
  2. Bunyamin Kisacik1,
  3. Vuslat Kecik Bosnak2,
  4. Ahmet Mesut Onat1
  1. 1Department of Rheumatology, Gaziantep University, Gaziantep, Turkey
  2. 2Department of Infectious Diseases and Clinical Microbiology, Gaziantep University, Gaziantep, Turkey
  1. Correspondence to Dr Yavuz Pehlivan, drpehlivan{at}hotmail.com

Summary

Demonstrating the efficiency and safety of rituximab (Rtx) in the treatment of active rheumatoid arthritis (RA) and tuberculosis (TB). Two cases of RA with active TB were followed up to 3 years following the initiation of Rtx. The former case presented with a history of concomitant diagnosis of both RA and TB and the latest one, also diagnosed with RA and reactivation of TB developed during the anti-tumour necrosis factor treatment. After a sufficient time of follow-up, we have observed that Rtx seems to be safer and efficient in the treatment of active RA and TB.

https://doi.org/10.1136/bcr-2012-006585

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text